Glaucoma Adherence Study

CompletedOBSERVATIONAL
Enrollment

55

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

February 28, 2010

Conditions
Ocular HypertensionPrimary Open Angle Glaucoma
Interventions
DRUG

Travoprost 0.004%/timolol 0.05% fixed combination eye drops (DuoTrav)

One drop in study eye(s) once daily in the evening for four months

DEVICE

Travalert Dosing Aid

Approved device used with DuoTrav and intended to provide an objective system for quantifying dosing and improving patient adherence

Trial Locations (4)

6229

Maastricht, Maastricht

20132

Milan, Milan

APE 000Z

France, Paris

Ec1V2PD

London, London

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY

NCT00676637 - Glaucoma Adherence Study | Biotech Hunter | Biotech Hunter